An evaluation of monitoring practices in patients on second generation antipsychotics.
about
Changes in body weight and psychotropic drugs: a systematic synthesis of the literatureVery low rates of screening for metabolic syndrome among patients with severe mental illness in Durban, South Africa.Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness.Psychiatric pharmacist integration into the medical homeTreatment strategies for dosing the second generation antipsychotics.Schizophrenia: women bear a disproportionate toll of antipsychotic side effects.Weight gain and metabolic syndrome among young patients on antipsychotic medication: what do we know and where do we go?Assessing clinicians' perspectives about the identification and management of antipsychotic medication side-effects: Psychometric evaluation of a survey questionnaire.Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.Mental health nurses' views about antipsychotic medication side effects.Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics.Barriers and solutions to implementing metabolic risk assessment in a secondary mental health service.To medicate or not to medicate, when diagnosis is in question: decision-making in first episode psychosis.Exploring nurses’ perceptions of antipsychotic medication side effects: a smallest space analysis
P2860
Q28728401-F1F60FD8-DD8D-41BB-8714-42614AF6DB55Q34109049-5BA5641B-2F6F-4D28-9F06-ABEB564E8FE6Q34631699-2E0EE517-0D02-4F9F-A413-AE280FD9E396Q36987106-E70AF4B4-39FF-4351-9ABB-02530ED358E2Q37407127-E945973A-90DC-4441-9BD6-AD05E1B56D12Q37852818-F06BB744-7FB3-4A0F-942E-35D817C561F6Q37887304-45C65395-BFA4-4626-870A-19B6C9E12FB0Q37891071-185565EC-9879-4F5A-B245-6DCAA16ACA53Q38719003-BAF5B81F-2019-4D5A-B0E9-15D5407F06C5Q43205612-FAD33BC8-3C19-4496-8F2D-C9BF37F5AEBAQ47992912-A871201A-2AE3-46A8-A008-F12970FEBFDAQ50072523-F09B140C-5524-42EA-8AE4-E657896A5FE1Q51847671-31088B08-8277-43AA-8710-660FF30172BCQ51855850-6DCEE4C4-4232-44AF-A86F-398348055B47Q58307984-BDE2BBDA-E6FC-43BD-9FFB-A816A26DA551
P2860
An evaluation of monitoring practices in patients on second generation antipsychotics.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
An evaluation of monitoring practices in patients on second generation antipsychotics.
@en
An evaluation of monitoring practices in patients on second generation antipsychotics.
@nl
type
label
An evaluation of monitoring practices in patients on second generation antipsychotics.
@en
An evaluation of monitoring practices in patients on second generation antipsychotics.
@nl
prefLabel
An evaluation of monitoring practices in patients on second generation antipsychotics.
@en
An evaluation of monitoring practices in patients on second generation antipsychotics.
@nl
P2093
P2860
P1476
An evaluation of monitoring practices in patients on second generation antipsychotics.
@en
P2093
Dang Nguyen
Philip Boyce
Vlasios Brakoulias
P2860
P304
P356
10.1080/10398560902842519
P577
2009-08-01T00:00:00Z